Novavax (NVAX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.12 +0.87%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $14 million versus the consensus estimate of $9.9 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Yum! Brands (YUM) PT Lowered to $180 at Argus
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
